Mortality after hip fracture in diabetic patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 7, 2011, Pages 414-418

  Gulcelik, N E ^a   Bayraktar, M ^a   Caglar, O ^a   Alpaslan, M ^a   Karakaya, J ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

diabetes mellitus; hip fracture; hyperglycemia; mortality

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C;

AGED; ARTICLE; COMORBIDITY; DIABETIC PATIENT; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIP FRACTURES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 79960197176     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1270466     Document Type: Article

References (33)

1. Christensen JO, Swendsen OL. Bone mineral in pre- and postmenopausal women with insulin dependent and non-insulin dependent diabetes mellitus. Osteoporosis Int 1999 10 307-311 (Pubitemid 29476195)
2. Cornwall R, Gilbert MS, Koval KJ et al,. Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics. Clin Orthop Relat Res 2004 425 64-71 (Pubitemid 39062751)
3. Epstein S, Leroith D. Diabetes and fragility fractures a burgeoning epidemic? Bone 2008 Jul 43 (1): 3-6
4. Forsen L, Sogaard AJ, Meyer HE et al,. Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int 1999 10 73-78 (Pubitemid 29428018)
5. Fox KM, Magaziner J, Hebel JR et al,. Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment and sequelae. J Gerontol A Biol Sci Med Sci 1999 54 M635-M640 (Pubitemid 30036428)
6. Goodson WH, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res 1997 221-227
7. Hadjidakis DI, Androulakis II, Mylonakis AM et al,. Diabetes in Postmenopause: Different Influence on Bone Mass According to Age and Disease Duration. Exp Clin Endocrinol Diabetes 2009 117 199-204
8. Haentejens P, Autier P, Barette M. et al on behalf of the hip fracture study group Survival and functional outcome according to hip fracture type: A one year prospective cohort study in elderly women with an intertorachanteric or femoral neck fracture. Bone 2007 41 958-964 (Pubitemid 350119866)
9. Johnell O, Kanis JA, Oden A. Mortality after osteoporotic fractures. Osteoporosis Int 2004 15 38-42 (Pubitemid 38252438)
10. Karagiannis A, Papakitsou E, Dretakis K et al,. Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type fracture. Calcif Tissue Int 2006 78 72-77 (Pubitemid 43228087)
11. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1993 307 1248-1250
12. Koval KJ, Aharonoff GB, Rokito AS et al,. Patients with femoral neck and intertochanteric fractures. Are they the same? Clin Orthop 1996 330 166-172 (Pubitemid 26304942)
13. Leibson CL, Tosteson AN, Gabriel SE et al,. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 2002 50 1644-1650 (Pubitemid 35192535)
14. Lieberman D, Fried V, Castel H et al,. Factors related to successful rehabilitation after hip fracture: a case control study. Disabil Rehabil 1996 18 224-230 (Pubitemid 26159913)
15. Lipscombe LL, Jamal SA, Booth GL et al,. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 2007 30 835-884
16. Matthaei S, Bierwirth R, Fritsche A et al,. Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus Update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes 2009 117 522-557
17. Mautalen CA, Vega EM. Different characteristics of cervical and trochanteric hip fractures. Osteoporos Int Suppl 1993 1 102-105 (Pubitemid 23099903)
18. McMurry J. Wound healing of diabetes mellitus: better glucose control for better wound healing in diabetes. Surg Clin North Am 1984 64 769-778 (Pubitemid 14071909)
19. Mizrahi EH, Fleissig Y, Arad M et al,. Functional outcome of elderly hip fracture patients: Does diabetes matter? Arch Gerontol and Geriartrics 2006 43 165-173 (Pubitemid 44233698)
20. Muraki S, Yamamoto S, Ishibashi H et al,. Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab 2006 24 100-104
21. Nakamura N, Kyou T, Takaoka K et al,. Bone mineral density in the proximal femur and hip fracture type in the elderly. J Bone Miner Res 1992 7 755-759
22. Nicodemus KK, Folsom AR. Iowa Women's Health Study. Type 1 and Type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001 7 1192-1197 (Pubitemid 33716397)
23. Paksima N, Koval KJ, Aharanoff G et al,. Predictors of Mortality after Hip Fracture. A 10 year prospective study. Bulletin of YU Hospital for Joint Diseases 2008 66 (2): 111-117 (Pubitemid 351898375)
24. Partanen J, Syrjala H, Vahanikkila H et al,. Impact of deep infection after hip fracture on function and mortality. Journal of hospital infection 2006 62 44-49 (Pubitemid 43103009)
25. Pietschmann P, Patsch JM, Schernthaner G. Diabetes and bone. Horm Metab Res 2010 Oct 42 (11): 763-768
26. Philip BK, Childress PJ, Robling AG et al,. RAGE supports parathyroid hormone-induced gains in femoral trabecular bone. Am J Physiol Endocrinol Metab 2010 Mar 298 (3): E714-E725
27. Piirtola M, Vahlberg T, Löppönen M et al,. Fractures as predictors of excess mortality in the aged A population-based study with a 12-year follow-up. Eur J Epidemoiol 2008 23 747-755
28. Schurman L, McCarthy AD, Sedlinsky C et al,. Metformin Reverts Deleterious Effects of Advanced Glycation End-Products (AGEs) on Osteoblastic Cells. Exp Clin Endocrinol Diabetes 2008 116 333-340 (Pubitemid 351947863)
29. Tang SY, Zeenath U, Vashishth D. Effects of non-enzymatic glycation on cancellous bone fragility. Bone 2007 Apr 40 (4): 1144-1151 (Pubitemid 46386561)
30. Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with a hip fracture effect of pre-morbid conditions and post-fracture complications. Osteoporosis Int 2007a 18 1583-1593 (Pubitemid 47620310)
31. Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J Am Geriatr Soc 2007b 55 (11): 1720-1726 (Pubitemid 350043786)
32. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes a meta-analysis. Osteoporosis Int 2007 18 427-444 (Pubitemid 46354916)
33. Zhou Z, Immel D, Xi CX et al,. Regulation of osteoclast function and bone mass by RAGE. J Exp Med 2006 Apr 17 203 (4): 1067-1080